Close

Rating History for Fusion Pharmaceuticals (FUSN) by Wedbush

More Stocks Rated by Wedbush | Latest Ratings for FUSN
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
3/19/2024 David Nierengarten Downgrade Neutral
(Outperform)		 24.00
(N/A)		 10.64
(21.24)		 99.62% Details